Journal Information

Most often read

22727
Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China
Xiaohui Wu, Zhishan Deng, Fan Wu, Youlan Zheng, Peiyu Huang, Huajing Yang, Ningning Zhao, Cuiqiong Dai, ... Yumin Zhou
Arch Bronconeumol. 2024;60:402-9
22727
Full text access
Open Article
20873
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Javier de Miguel-Díez, Julio Núñez Villota, Salud Santos Pérez, Nicolás Manito Lorite, Bernardino Alcázar Navarrete, Juan Francisco Delgado Jiménez, Juan José Soler-Cataluña, Domingo Pascual Figal, ... Juan José Gómez Doblas
Arch Bronconeumol. 2024;60:226-37
20873
Full text access
Open Article
16876
Hypersensitivity Pneumonitis-like Histological Findings Secondary to SARS-COV-2 Pneumonia
Cristina Aljama, María Florencia Pilia, Iñigo Ojanguren
Arch Bronconeumol. 2024;60:435-6
16876
15461
Determinants of COVID-19 Hospitalization Costs in a Referral Hospital for Respiratory Diseases
David Martínez-Briseño, Rosario Fernández-Plata, Rogelio Pérez-Padilla, Anjarath Higuera-Iglesias, Manuel Castillejos-López, Guillermo Casas-Medina, Patricia Sierra-Vargas, Víctor Hugo Ahumada-Topete
Arch Bronconeumol. 2024;60:246-9
15461
Open Article
15391
Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 Patient
Manel Luján, César Cinesi Gómez, Oscar Peñuelas, Carlos Ferrando, Sarah Béatrice Heili-Frades, José Manuel Carratalá Perales, Arantxa Mas, Javier Sayas Catalán, ... Carlos Egea Santaolalla
Arch Bronconeumol. 2024;60:285-95
15391
Open Article
12828
Erratum to “Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia” [Archivos de Bronconeumologia 59 (2023) 63–65]
Esther Palones, Elena Curto, Anna Pelegrí, Marina Arilla, Ingrid Solanes, Astrid Crespo-Lessmann
Arch Bronconeumol. 2024;60:69
12828
Open Article
12079
Persistent Pulmonary Fibrotic Sequelae in Patients With Telomere Shortening One Year After Severe COVID-19
Alba Mulet, Pilar González-Cabo, Federico V. Pallardó, Jaime Signes-Costa
Arch Bronconeumol. 2024;60:62-4
12079
Full text access
Open Article
11800
Potential Benefits of a Cardiovascular Polypill in Long COVID Patients
Joan B. Soriano
Arch Bronconeumol. 2024;60:263-4
11800
Open Article
9081
CO1
Arch Bronconeumol. 2024;60:CO1
9081
Full text access
Open Article
8313
Editorial Board
Arch Bronconeumol. 2024;60:i
8313
Full text access
Open Article
7025
The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen Therapy
Mara Paneroni, Alessandro Cavicchia, Salvi Beatrice, Laura Bertacchini, Massimo Venturelli, Michele Vitacca
Arch Bronconeumol. 2024;60:410-6
7025
Highlights

  • Factors that influence muscle fatigability (MF) after exercise in COPD were studied.

  • COPD patients with very severe (VSO) and severe lung obstruction (SO) were compared.

  • VSO patients experience lower MF (less reduction in MVC) compared to SO.

  • Dyspnea is higher in the VSO group at the beginning and end of the exercise.

6611
Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
Thomas Villeneuve, Laurent Guilleminault, Nicolas Guibert
Arch Bronconeumol. 2024;60:600-1
6611
Full text access
Open Article
6303
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Alvar Agusti, José Luis Lopez-Campos, Marc Miravitlles, Juan Jose Soler-Cataluña, Jose Maria Marin, Borja G. Cosio, Bernardino Alcázar-Navarrete, Jose Maria Echave-Sustaeta, ... Bartolome R. Celli
Arch Bronconeumol. 2024;60:417-22
6303
Full text access
Open Article
5998
Arthritis, Pulmonary Cysts and Renal Insufficiency: COPA Syndrome
María Nieves Balaguer Cartagena, Carles Fonfría Esparcia, Gabriel Anguera de Francisco
Arch Bronconeumol. 2024;60:535-6
5998
5715
Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
Esther Redondo, Irene Rivero-Calle, Enrique Mascarós, Daniel Ocaña, Isabel Jimeno, Ángel Gil, Manuel Linares, María Ángeles Onieva-García, ... Federico Martinón-Torres
Arch Bronconeumol. 2024;60:161-70
5715
Full text access
Open Article
5473
Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review
Cristina Jácome, Marta Jácome, Sara Correia, Inês Flores, Patrícia Farinha, Mónica Duarte, João Carlos Winck, Javier Sayas Catalan, ... Cátia Caneiras
Arch Bronconeumol. 2024;60:490-502
5473
Full text access
Open Article
4965
New Vaccines for Chronic Respiratory Patients
Narmeen Mallah, Ana Dacosta Urbieta, Irene Rivero-Calle, Francisco-Javier Gonzalez-Barcala, Tommaso Bigoni, Alberto Papi, Federico Martinón-Torres
Arch Bronconeumol. 2024;60:565-75
4965
Full text access
Open Article
4175
Corrigendum to “Chronic respiratory diseases as a risk factor for herpes zoster infection” [Arch Bronconeumol. 2024;59(12):797–804]
Diego Morena, Sara Lumbreras, José Miguel Rodríguez, Carolina Campos, María Castillo, María Benavent, José Luis Izquierdo
Arch Bronconeumol. 2024;60:539-40
4175
Full text access
Open Article
4093
Local Anesthetic Thoracoscopy: A Focus on Indications, Techniques and Complications
Michele Piazzolla, Cosimo C. De Pace, José M. Porcel, Pasquale Tondo
Arch Bronconeumol. 2024;60:423-30
4093
4088
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Alberto Papi, Franco Alfano, Tommaso Bigoni, Lorenzo Mancini, Amal Mawass, Federico Baraldi, Cristina Aljama, Marco Contoli, Marc Miravitlles
Arch Bronconeumol. 2024;60:269-78
4088
Highlights

  • Treatment effects on PROs in chronic bronchitis (CB) with/out COPD are scarcely known.

  • N-acetylcysteine (NAC) improve symptoms and/or QoL in studies conducted in CB.

  • NAC reduce exacerbations in studies conducted in subjects with CB.

  • Similarly, NAC reduce exacerbations and improve symptoms and/or QoL in COPD studies.

Full text access
Open Article
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?